#	Pagina
attuale pagina	/open-h2020/projects/205780/index.html

Opendata, web and dolomites

CIRDinnova SIGNED

Shifting the limits of resuscitation with “CIRD Controlled Integrated Resuscitation Device”

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

CIRDinnova project word cloud

Explore the words cloud of the CIRDinnova project. It provides you a very rough idea of what is the project "CIRDinnova" about.

progress resuscitec nl international group hospitals consisting device death renowned decades therapeutic rapid reperfusion decline resuscitation company de scientific ten industrial tending shown full worldwide completely outcome hospital founded therapy patient designation trl thereafter automated innovative rescue close commercialisation survival led execute body improvement 18 humans cpr zero university minutes freiburg innovation beyersdorf cird breakthrough successful cardiac game sudden linz 2010 reached personalized intensive first start prof introduces changing off patients spin survive rotterdam surgeon market emergency arrest time minute action medicine carl started ago frame causes individual 3 frequent medical clinical

Project "CIRDinnova" data sheet

The following table provides information about the project.

Coordinator	UNIVERSITAETSKLINIKUM FREIBURG Organization address address: HUGSTETTER STRASSE 49 city: FREIBURG postcode: 79106 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Germany [DE]
Project website	http://www.resuscitec.de/index_en.html
Total cost	2˙923˙723 €
EC max contribution	2˙277˙959 € (78%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2. (PRIORITY 'Industrial leadership')
Code Call	H2020-FTIPilot-2016-1
Funding Scheme	IA
Starting year	2016
Duration (year-month-day)	from 2016-12-01 to 2020-05-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	UNIVERSITAETSKLINIKUM FREIBURG UNIVERSITAETSKLINIKUM FREIBURG Organization address address: HUGSTETTER STRASSE 49 city: FREIBURG postcode: 79106 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (FREIBURG)	coordinator	369˙701.00
2	RESUSCITEC GMBH RESUSCITEC GMBH Organization address address: ROTTECKRING 4 city: FREIBURG IM BREISGAU postcode: 79098 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (FREIBURG IM BREISGAU)	participant	1˙506˙782.00
3	KEPLER UNIVERSITATSKLINIKUM GMBH KEPLER UNIVERSITATSKLINIKUM GMBH Organization address address: KRANKENHAUSSTRASSE 7A city: LINZ postcode: 4020 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (LINZ)	participant	203˙353.00
4	ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM Organization address address: DR MOLEWATERPLEIN 40 city: ROTTERDAM postcode: 3015 GD website: www.erasmusmc.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (ROTTERDAM)	participant	198˙121.00

Map

Project objective

Sudden cardiac arrest is one of the most frequent causes of death. But only 3% of the patients survive out-of-hospital resuscitation, and only 18% survive in-hospital resuscitation. Today the time-frame for successful resuscitation is only about 3 to 5 minutes after cardiac arrest. Thereafter, with every minute a rapid decline in survival is observed, tending to “zero” beyond ten minutes of CPR. For decades no significant improvement of the clinical outcome and no significant scientific progress in resuscitation could be shown! More than 10 years ago a research group led by the international renowned cardiac surgeon Prof F Beyersdorf at the Freiburg University Hospital started intensive clinical R&D to develop a completely new therapeutic concept for resuscitation The new therapeutic concept enables a game changing breakthrough in resuscitation therapy. It is patient-individual and introduces for the first time a controlled, automated and personalized medical therapy in emergency medicine. The designation for the therapy is “CARL – Controlled Automated Reperfusion of the whoLe body”. To bring this new therapy worldwide into the hospitals and rescue organisations a new start-up company – the ResuSciTec GmbH - has been founded as a Spin-off from the Freiburg University Hospital in 2010. In close collaboration with the Freiburg University Hospital ResuSciTec developed an innovative system of medical devices called “CIRD - Controlled Integrated Resuscitation Device”. First very promising results from a clinical study in humans are already available. That means ResuSciTec has reached TRL 7. To reach TRL 9 and to start full international commercialisation and wide market take-up a consortium consisting of ResuSciTec as industrial partner and three university hospital in Freiburg (DE), Linz (AT) and Rotterdam (NL) will execute the proposed innovation action.

Deliverables

List of deliverables.
Market approval for CIRD 2.0 (CE)	Other	2019-08-05 15:07:06

Take a look to the deliverables list in detail: detailed list of CIRDinnova deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CIRDINNOVA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CIRDINNOVA" are provided by the European Opendata Portal: CORDIS opendata.